Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,760 across all filing types
Latest filing 2024-06-29 Environmental & Social …
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Updates
Environmental & Social Information Classification · 95% confidence The document is a detailed Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March 2024, which is explicitly stated to form part of the Annual Report for FY 2023-24. The content includes extensive disclosures on sustainability, corporate responsibility initiatives, governance, employee data, and environmental and social governance (ESG) factors. It references compliance with SEBI regulations and national guidelines for responsible business conduct. The length of the document (15,000 characters) and the detailed nature of the content indicate it is the report itself, not merely an announcement or a certification. The focus on sustainability and ESG aligns with the category Environmental & Social Information (SR). Although it is part of the Annual Report, the document specifically focuses on sustainability and business responsibility, which fits best under the Environmental & Social Information category rather than the full Annual Report (10-K).
2024-06-29 English
Shareholders meeting
Regulatory Filings
2024-06-29 English
Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company
Regulatory Filings
2024-06-29 English
Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company
Environmental & Social Information Classification · 95% confidence The document is a detailed Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March 2024, which is part of the Integrated Annual Report 2023-24 of Torrent Pharmaceuticals Limited. It includes extensive disclosures on sustainability, corporate responsibility initiatives, governance, environmental and social factors, and performance metrics aligned with ESG frameworks such as GRI, SASB, and UN SDGs. The document references the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, specifically Regulation 34(2)(f), which mandates such disclosures. The content is comprehensive and substantive, covering environmental, social, governance, and sustainability performance, which aligns with the definition of Environmental & Social Information (Code: SR). It is not merely an announcement or a brief summary but a full report on sustainability and business responsibility. Therefore, the appropriate classification is Environmental & Social Information (SR).
2024-06-29 English
Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means
Regulatory Filings
2024-06-29 English
Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for designated persons in compliance with the company's code of conduct and SEBI regulations. It mentions the trading window closure period related to the submission of quarterly financial results but does not contain any financial data or detailed report. The document is an announcement related to trading restrictions rather than a financial report or detailed filing. Given its brief nature and regulatory compliance context, it fits best under Regulatory Filings (RNS).
2024-06-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.